marijuana stocks

NTRR Builds Customer Awareness at CannaCon

Neutra Corp. (NTRR) representatives attended last week’s CannaCon expo seeking new partners and opportunities in Washington’s burgeoning cannabis marketplace. CannaCon, the nation’s largest cannabis exposition, is a three-day event that seeks to unite all levels of cannabusiness exhibitors, suppliers and marketers.

NTRR attended the event to seek out new opportunities to test and promote a suite of products developed by its joint venture partner, Surface to Air Solutions(S2O2). The joint venture is promoting the use of Purteq Photocatalyst, its environmentally friendly antimicrobial surface treatment to protect indoor crops from mold, bacteria and pests; its NanoGro photosynthesis accelerator for rapid plant growth; and its hydroxyl generators to improve air quality.

“CannaCon is a premiere networking opportunity for cannabusiness ventures,” said NTRR CEO Chris Brown. “Rising acceptance of cannabis legalization in the U.S. is driving up demand for our services. Finding horticulture partners and testing facilities for our products in the state of Washington is a priority for our company, and we’ll continue to follow up on the leads we gained at the conference.”

Attendance of this year’s CannaCon drew big crowds over its February 19-21 run at Seattle’s Pier 91 Smith Cove Event Center. NTRR continues to position itself as a leader in the emerging $2.7 billion U.S. cannabis market with innovative products and services to showcase in Washington, Colorado and beyond.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By delivering a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), Growlife Inc. (PHOT) and Medbox Inc. (MDBX) and other leaders in the fast-growing, billion-dollar U.S. cannabis industry. For investing information and performance data, please visitwww.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that includes the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

MariMed Inc. (MRMD) Announces Third Quarter 2024 Earnings Date

MariMed Announces Third Quarter 2024 Earnings Date MariMed Inc. (“MariMed” or the…

CannTrust Holdings Inc. (CNTTF) to Proceed Immediately with Phase III Construction in Town of Pelham

CannTrust to Proceed Immediately with Phase III Construction in Town of Pelham…

Tilray Brands, Inc. (TLRY) Launches Broken Coast Medical Cannabis Brand in Australia

Tilray Medical Launches Broken Coast Medical Cannabis Brand in Australia Tilray Medical,…

 Tetra Bio-Pharma Inc. (TBPMF) Announces Divestiture of Lumiera Health Innovation Inc.

Tetra Bio Pharma Announces Divestiture of Lumiera Health Innovation Inc. Tetra Bio-Pharma…